Viking Therapeutics
VKTX
VKTX
138 hedge funds and large institutions have $227M invested in Viking Therapeutics in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 52 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
25% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 52
Holders
138
Holding in Top 10
–
Calls
$7.14M
Puts
$1.7M
Top Buyers
| 1 | +$1.96M | |
| 2 | +$1.46M | |
| 3 | +$669K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$573K |
| 5 |
PP
PDT Partners
New York
|
+$569K |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$2.3M | |
| 3 | -$1.77M | |
| 4 |
Aviva
London,
United Kingdom
|
-$1.31M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.2M |